VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253 | -38.4% | 26,982 | +61.0% | 0.02% | -40.6% |
| Q2 2023 | $411 | +3.5% | 16,762 | -1.9% | 0.03% | +10.3% |
| Q1 2023 | $397 | -2.9% | 17,081 | +5.6% | 0.03% | -14.7% |
| Q4 2022 | $409 | -99.9% | 16,178 | -24.0% | 0.03% | -10.5% |
| Q3 2022 | $410,000 | -14.9% | 21,284 | +12.4% | 0.04% | -13.6% |
| Q2 2022 | $482,000 | +52.5% | 18,939 | +54.2% | 0.04% | +340.0% |
| Q1 2022 | $316,000 | – | 12,283 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |